On May 23, 2025, Clearside Biomedical (CLSD, Financial) was the subject of a recent analyst update by HC Wainwright & Co. Analyst Yi Chen has maintained a "Buy" rating for the stock. The decision to uphold this recommendation demonstrates a continued confidence in Clearside Biomedical's strategic direction and market potential.
However, HC Wainwright & Co. made adjustments to the price target for Clearside Biomedical (CLSD, Financial). The price target has been lowered from a previous target of $6.00 to a current target of $5.00, reflecting a decrease of 16.67%. This change indicates a more cautious outlook on the stock's valuation in the near term.
The adjustment in price target aligns with broader market strategies and investment considerations, yet the maintained "Buy" rating suggests potential growth opportunities for investors in the long run. Investors in Clearside Biomedical (CLSD, Financial) should consider this updated information when evaluating their investment strategy moving forward.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 7 analysts, the average target price for Clearside Biomedical Inc (CLSD, Financial) is $5.57 with a high estimate of $8.00 and a low estimate of $3.00. The average target implies an upside of 553.20% from the current price of $0.85. More detailed estimate data can be found on the Clearside Biomedical Inc (CLSD) Forecast page.
Based on the consensus recommendation from 7 brokerage firms, Clearside Biomedical Inc's (CLSD, Financial) average brokerage recommendation is currently 1.7, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Clearside Biomedical Inc (CLSD, Financial) in one year is $0.39, suggesting a downside of 54.28% from the current price of $0.85295. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Clearside Biomedical Inc (CLSD) Summary page.
